{
  "x402Version": 2,
  "id": 4551,
  "slug": "4551",
  "resource": "https://clinicalintelpulse.theaslangroupllc.com/api/clinical/pipeline-scan",
  "description": "Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ trials worldwide. For biotech-investing and pharma agents.",
  "type": "http",
  "accepts": [
    {
      "scheme": "exact",
      "network": "eip155:8453",
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
      "amount": "150000",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "eip155:8453",
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
      "amount": "150000",
      "maxTimeoutSeconds": 604900
    },
    {
      "scheme": "exact",
      "network": "solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp",
      "payTo": "985iFjbnGQ3dJcwXnfRCMSrH4Jnc3kW1N6msR64B5KX1",
      "asset": "EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v",
      "amount": "150000",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "eip155:137",
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "asset": "0x3c499c542cEF5E3811e1192ce70d8cC03d5c3359",
      "amount": "150000",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "eip155:42161",
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "asset": "0xaf88d065e77c8cC2239327C5EDb3A432268e5831",
      "amount": "150000",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "eip155:480",
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "asset": "0x79A02482A880bCe3F13E09da970dC34dB4cD24D1",
      "amount": "150000",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "eip155:143",
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "asset": "0x754704Bc059F8C67012fEd69BC8A327a5aafb603",
      "amount": "150000",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "eip155:196",
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "asset": "0x779ded0c9e1022225f8e0630b35a9b54be713736",
      "amount": "150000",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "eip155:999",
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "asset": "0xb88339CB7199b77E23DB6E890353E22632Ba630f",
      "amount": "150000",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k",
      "payTo": "62A253YPATFNJCPRKID3FKD77MYJFNTVRYRP4B4JWG36EGLPY7UXFWGI7I",
      "asset": "31566704",
      "amount": "150000",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "xrpl:0",
      "payTo": "rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32",
      "asset": "XRP",
      "amount": "150000",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "xrpl:0",
      "payTo": "rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32",
      "asset": "524C555344000000000000000000000000000000",
      "amount": "0.15",
      "maxTimeoutSeconds": 300
    },
    {
      "scheme": "exact",
      "network": "eip155:56",
      "payTo": "0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc",
      "asset": "0x8d0D000Ee44948FC98c9B98A4FA4921476f08B0d",
      "amount": "150000000000000000",
      "maxTimeoutSeconds": 300
    }
  ],
  "outputSchema": {
    "bazaar": {
      "info": {
        "input": {
          "method": "GET",
          "queryParams": {
            "condition": "Disease or condition — e.g. \"Non-Small Cell Lung Cancer\" | \"Alzheimer Disease\" | \"Type 2 Diabetes\" | \"Crohn Disease\" | \"Multiple Myeloma\"",
            "lang": "en | es | fr | de | ja | zh | ko | pt | ar | hi (default: en)",
            "phase": "phase2 | phase3 | both (default: both)",
            "status": "active | all (default: active — recruiting + active not recruiting)"
          },
          "type": "http"
        },
        "output": {
          "example": {
            "approved_drugs_context": "NSCLC has 30+ FDA-approved agents. Pipeline is additive rather than disruptive in most cases.",
            "geographic_distribution": {
              "asia_pct": 22,
              "europe_pct": 28,
              "most_active_countries": [
                "United States",
                "China",
                "Germany",
                "South Korea",
                "Japan"
              ],
              "other_pct": 5,
              "us_trials_pct": 45
            },
            "mechanism_breakdown": {
              "adc": 18,
              "bispecific": 12,
              "chemo_combinations": 31,
              "io_checkpoint_inhibitors": 62,
              "other": 81,
              "targeted_therapy": 41
            },
            "phase3_highlights": [
              {
                "countries": [
                  "United States",
                  "Germany",
                  "Japan",
                  "South Korea"
                ],
                "nctId": "NCT05116748",
                "primaryCompletion": "2026-03",
                "sponsor": "Merck",
                "status": "RECRUITING",
                "title": "Pembrolizumab + Carboplatin vs SOC in NSCLC"
              }
            ],
            "pipeline_assessment": "Extremely crowded pipeline — PD-1/L1 space saturated. ADCs and bispecifics represent highest differentiation potential. KRAS G12C targeted therapies emerging as new standard.",
            "pipeline_totals": {
              "phase2_count": 156,
              "phase3_count": 89,
              "total_active": 245
            },
            "query_summary": {
              "condition": "Non-Small Cell Lung Cancer",
              "phases_searched": [
                "PHASE2",
                "PHASE3"
              ],
              "status_filter": "RECRUITING,ACTIVE_NOT_RECRUITING"
            },
            "sponsor_landscape": {
              "academic_sponsors": "ECOG-ACRIN, Alliance, NCI leading academic cooperative groups",
              "emerging_biotechs": [
                "Turning Point Therapeutics",
                "Blueprint Medicines",
                "Mirati Therapeutics"
              ],
              "top_industry_sponsors": [
                "Roche/Genentech (18 trials)",
                "Bristol-Myers Squibb (14)",
                "AstraZeneca (13)",
                "Merck (12)",
                "Pfizer (11)"
              ]
            }
          },
          "type": "json"
        }
      },
      "schema": {
        "$schema": "https://json-schema.org/draft/2020-12/schema",
        "properties": {
          "input": {
            "additionalProperties": false,
            "properties": {
              "method": {
                "enum": [
                  "GET",
                  "HEAD",
                  "DELETE"
                ],
                "type": "string"
              },
              "queryParams": {
                "properties": {
                  "condition": {
                    "type": "string"
                  },
                  "lang": {
                    "type": "string"
                  },
                  "phase": {
                    "type": "string"
                  },
                  "status": {
                    "type": "string"
                  }
                },
                "type": "object"
              },
              "type": {
                "const": "http",
                "type": "string"
              }
            },
            "required": [
              "type",
              "method"
            ],
            "type": "object"
          },
          "output": {
            "properties": {
              "example": {
                "type": "object"
              },
              "type": {
                "type": "string"
              }
            },
            "required": [
              "type"
            ],
            "type": "object"
          }
        },
        "required": [
          "input"
        ],
        "type": "object"
      }
    },
    "builder-code": {
      "info": {
        "a": "bc_gxy6qn5p"
      },
      "schema": {
        "$schema": "https://json-schema.org/draft/2020-12/schema",
        "additionalProperties": false,
        "properties": {
          "a": {
            "description": "App builder code",
            "pattern": "^[a-z0-9_]{1,32}$",
            "type": "string"
          },
          "s": {
            "description": "Service builder codes",
            "items": {
              "pattern": "^[a-z0-9_]{1,32}$",
              "type": "string"
            },
            "type": "array"
          },
          "w": {
            "description": "Wallet builder code",
            "pattern": "^[a-z0-9_]{1,32}$",
            "type": "string"
          }
        },
        "type": "object"
      }
    }
  },
  "tags": [
    "bazaar",
    "builder-code"
  ],
  "sourceHost": "clinicalintelpulse.theaslangroupllc.com",
  "lastUpdated": "2026-08-20T14:01:56.821Z",
  "quality": {
    "calls30d": 1,
    "uniquePayers30d": 1,
    "lastCalledAt": "2026-08-20T14:01:56.594Z"
  },
  "liveness": {},
  "verified": false,
  "featured": false,
  "provider": {
    "host": "clinicalintelpulse.theaslangroupllc.com",
    "manifest_name": "clinicalintelpulse.theaslangroupllc.com",
    "source": "cdp-mirror",
    "source_manifest_url": "https://api.cdp.coinbase.com/platform/v2/x402/discovery/resources",
    "submitted_at": "2026-09-18T22:00:31.484Z"
  }
}